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An aryl sulfotransferase, whose cDNA was isolated from the rat liver library, was found to catalyze bioactivation of minoxidil through N-O-sulfation
and N-sulfation of a carcinogenic heterocyclic amine, IQ, by expression in COS-1 cells. cDNA of a human ortholog also was isolated and characterized
as a major minoxidil-activating enzyme in human liver. Another group of aryl sulfotransferases catalyzing O-sulfation of carcinogenic N-hydroxyarylamines
was separated from livers of rats and humans. These sulfotransferases have been shown to possess similar functional properties and also to relate
immunochemically with each other. Current understanding on the primary structure of these sulfotransferases also is discussed. - Environ Health
Perspect 102(Suppl 6):99-103 (1994)
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Introduction
Sulfation is a major metabolic pathway of
xenobiotics and endobiotics and also is
known to take part in the metabolic activa-
tion of toxic and carcinogenic N-substi-
tuted aryl compounds. These sulfations are
catalyzed by a group ofsulfotransferase in
livers and other tissues. Extensive studies
indicate that multiple forms ofaryl (phenol)
sulfotransferase with distinct catalytic and
immunologic properties are contained in
experimental animal species (1,2). Recent
studies also have provided evidence that
human liver contains multiple forms ofaryl
sulfotransferases (3).
Enormous progress has been made
within the past 10 years for understanding
the structure ofdrug-conjugating enzymes
such as glutathione transferase, glucuronyl-
transferase, and acetyltransferase at molecular
levels. The information on sulfotransferase,
however, remained unclear. Therefore, we
have conducted studies for a few years to
obtain structural information on the primary
structure of this enzyme by molecular
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cloning (4-6) as a first step to understand
the exact role of this enzyme in drug and
carcinogen activation. In this article, rat
and human aryl sulfotransferases are char-
acterized by their cDNA expression. In
addition, properties and relationships ofN-
hydroxyarylamine sulfotransferases in rats
and humans are shown.
Experimental Procedure
Chemicals used and methods for assays of
sulfotransferase activity and covalent bind-
ing to DNA are the same as described pre-
viously (7,8). Minoxidil sulfation was
determined by the method ofJohnson and
Baker (9). Isolation and characterization of
sulfotransferase cDNAs were performed as
described (6,10). Experimental details for
animal treatments were done as described
in our previous reports (11,12).
Isolation of Aryl
Sulfotransferase cDNAs
As reported previously (6), we isolated a
cDNA (PST-1) encoding a rat aryl sulfo-
transferase by the use ofanti-arylsulfotrans-
ferase antibodies. PST-1 consisted of 1028
nucleotides and contained an open reading
frame of 873 nucleotides encoding a 291
amino acid protein. Another clone-related
PST-1, but showing a longer nucleotide
length, was isolated recently by further
screening of a rat liver cDNA library with
PST-1. The cDNA (PST-lv) contained a
coding sequence identical to PST-1 but
had extended 5'-flanking (12 base) and 3'-
untranslated regions (196 base) (Figure 1).
Consistent with the isolation of two
cDNAs with different sizes, two distinct
hybridized bands were detected with 32p-
labeled PST-1 at around 15S and 16S in
Northern blots of rat RNAs. These bands
were detected in livers and kidneys ofboth
sexes and showed no clear sex-related dif-
ference. A hybridizable band also was
detected in the RNA samples of brain,
heart, and colon tissues, suggesting that
STIAI encoded by PST-1 is expressed in
various extrahepatic tissues.
Characterization of Phenol
Sulfotransferase cDNAs
As shown in Figure 2, transfection of a
construct containing PST-1 with normal
(syn), but not opposite (anti), orientation
resulted in the expression of a sulfotrans-
ferase (STlAl) in COS-1 cells. STlAl
migrated to a position identical with a
major immunodetectable protein (32.5
kDa) in rat livers in SDS-polyacrylamide
gel electrophoresis and Western blotting.
STIAI constituted nearly 0.2% of total
cytosolic protein in the transfected COS-1
cells, and this level corresponded roughly
to half of the specific content (Western
blot's intensity per milligram protein) in
rat livers.
Expressed-STlAl catalyzed sulfation of
simple phenols such as p-nitrophenol and
1-naphthol in the presence ofPAPS (Table
1). The rate ofsulfation ofp-nitrophenol
was 2- to 3-fold higher at pH 5.5 than at
pH 7.4. A similar phenomenon also was
observed in hepatic cytosols of rats. The
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Figure 1. Nucleotide sequences of PST-1 and a variant clone (PST-lv) encoding STlAl. Only the 5' and 3' ends of
both cDNA sequences are shown. Initiation and termination codons, ATG and TGA, are indicated in bold letters
and asterisks, respectively. Complete identitywas observed on their amino acid-coding sequences.
Table 1. Sulfating activities of STlAl expressed in COS-1 cells.
Activity, pmole/mg protein/mina
Cytosol Minoxidil p-Nitrophenol 1-Naphthol N-OH-AAF
pH 7.4 pH 5.5
Male rat liver 590 480 2790 3700 380
COS-1/PST-1b(syn)c 170 80 214 740 6
COS-1/PST-1 (ant,)c <7 days < 5 days < 5days < 10days <3 days
'Activities were determined at pH 7.4 for sulfations of minoxidil and p-nitrophenol, and at pH 5.5 for sulfation of
1-naphthol, N-hydroxy-2-acetylaminofluorene (N-OH-AAF), and p-nitrophenol. bPST-1 is a cDNA clone of STlAl.
CSyn and anti indicate introduction of PST-1 in normal and opposite directions, respectively. dBelow the limits of
detection.
Figure 2. Western blots of STlAl expressed in COS-1
cells. Syn and antiindicate introduction of PST-1 in nor-
mal and opposite directions, respectively.
rates ofp-nitrophenol and 1-naphthol sul-
fation in COS-1 cells were, in spite of
lesser specific contents ofSTIAI, nearly 10
to 20% of the rates observed in liver
cytosols of rats. These results suggest the
substantial contribution of STIAl on
hepatic sulfation ofboth phenols in rats.
Minoxidil (Figure 3) is known to exert
pharmacologic (cardiovascular and hair
growth stimulating) effects through conver-
sion into the N-O-sulfate (13,14).
Interestingly, STIAI mediated this activa-
tion at fairly high rates. The kinetic profiles
of this reaction also were determined and
found to have similar K values for minox-
idil among cytosol systems containing
STIAI-expressed COS-1 cells, livers of
male or female rats (Figure 4). N-O-
Sulfation is established as a major bioacti-
vating pathway for N-hydroxy derivatives
of carcinogenic arylamines. STIAI cat-
alyzed N-O-sulfation of minoxidil. Thus,
N-O-sulfation ofN-hydroxy-2-acetylamino-
fluorene was examined but was catalyzed to
only limited extents by STIAL.
More than 10 heterocyclic amines have
been isolated from cooked foods and protein
pyrolysates and have been shown to be
mutagenic in Salmonella and carcinogenic
to experimental animals (15). Recent studies
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Figure 3. Chemical structures ofaryl sulfotransferase substrates.
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Figure 4. Lineweaver-Burk plots of minoxidil sulfation
in cytosols of COS-1 cells, male and female rat livers.
Minoxidil sulfation was determined using a concentra-
tion range of 62.5 to 4000 pM. Kms for minoxidil were
calculated as 560 pM in COS-1, 550 pM in male rat,
and 470 pM in female rat systems.
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Table 2. N-Sulfation of heterocyclic amines by STlAl
expressed in COS-1 cells.
Rat livers
Chemicals COS-1 cells Male Female Human liver
IQ 32.9 70.9 46.6 0.3
MelQx 20.4 42.1 23.4 <0.2
PhIP < 1 7.3 42.2 < 0.2
Glu-P-1 < 1 6.8 15.4 <0.2
Trp-P-2 < 1 4.8 11.4 <0.2
Abbreviations: IQ, 2-amino-3-methylimidazo[4,5-f]
quinoline; MelQx, 2-amino-3,8-dimethylimidazo[4,5-fI
quinoxaline; PhIP, 2-amino-1-methyl-6-phenylimidazo
[4,5-b]pyridine; Glu-P-1, 2-amino-6-methyldipyrido[1,2-
a::3',2'-d]imidazole; Trp-P-2, 3-amino-i-methyl-5H-
pyrido[4,3-b]indole. Activities (pmole/min/mg protein)
were determined at the concentration of 1 mM for
these carcinogenic heterocyclic amines.
of their in vivo metabolism showed that
heterocyclic amines with an aminoazaarene
moiety were excreted to considerable
extents as the N-sulfates (sulfamates)
(16,17). Therefore, we examined N-sulfa-
tion of typical azaarenes and carbolines
using liver cytosols of rats and humans as
well as cytosols ofSTIAl-expressed COS-1
cells. As described in Table 2, all the hetero-
cyclic amines examined were N-sulfated in
rat liver cytosol systems. Extents ofsulfation
were the highest on 2-amino-3-methylimi-
dazo[4,5-flquinoline (IQ) in hepatic
cytosols ofboth sexes. N-Sulfations of IQ
and MeIQx showed male dominance,
while N-sulfations of three other amines
were higher in females than males. STlAl
catalyzed N-sulfation ofIQ and MeIQx at
comparable rates as a sulfotransferase in rat
livers but was devoid ofdetectable activity
for other heterocyclic amine substrates.
Human liver cytosol also catalyzed N-sulfa-
tion of IQ at low rates, but showed no
detectable activity on other amines. These
results indicate that plural forms, STIAl
and another form ofsulfotransferase (likely
to be a female-dominant form), catalyzed
N-sulfation ofarylamines in rat livers.
Using STIAl cDNA (PST-1), a cDNA
library of a human liver was screened to
isolate a human sulfotransferase cDNA
related to STIAI. A clone with a 1.0-Kb
insert was isolated and found to contain
information of a human sulfotransferase
(ST1A2). The isolated cDNA covered
almost the entire coding sequence and
showed a 77% homology to STlAl. To
assess the cDNA encoding a functionally
active enzyme, the cDNA was expressed in
Escherichia coli using an ATG-containing
vector. In Western blots with anti-rat sulfo-
transferase antibodies, both the expressed
protein and human cytosol were immuno-
stained at an identical mobility. Similar to
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Figure 5. Effect of gonadectomy on HAST content in
rat liver. Cont, intact animals; Cast, castrated male; Ov,
ovariectomized female; and T, testosterone treatment.
Hepatic contents of HAST in Sprague-Dawley rats
were determined by Western blotting using polyclonal
anti-HAST antibodies.
the rat counterpart, expressed-STIA2 cat-
alyzed sulfation of minoxidil and p-nitro-
phenol. Levels ofimmunodetectable STIA
protein in human livers varied more than
10-fold and showed a good correlation
with the extents of minoxidil sulfation in
individual human cytosols (r = 0.80).
These results suggest that ST1A2 encodes a
major sulfotransferase catalyzing minoxidil
bioactivation in humans.
Characterization of
N-Hydroxyarylamine
Suffotransferase
Arylamines produce mostly tumors in livers
ofexperimental animals. The incidence is
often higher in male rats than in females
(18-20). Studies from several laboratories
established the major role ofmale-dominant
sulfation on the occurrence of the sex-
related difference in the arylamine-induced
liver carcinogenesis in this species (20-22).
The enzymes mediating this activation also
have been isolated from several laboratories
(8,23,24). Exact identification ofthe iso-
lated proteins is, however, notyet performed,
because ofthe instability ofpurified proteins.
We purified two distinct but immuno-
chemically related forms of sulfotrans-
ferases (HAST I and HAST II) from livers
ofadult male rats (8). Both forms catalyze
sulfations ofp-nitrophenol and N-hydroxy-
2-acetylaminofluorene, and mediated
PAPS-dependent DNA binding of N-
hydroxy-2-acetylaminofluorene in the
reconstituted system. As shown in Figure 5,
immunodetectable amounts of HASTs
were 3- to 4-fold higher in male than in
female rats and decreased to a level of
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Figure 6. Developmental changes in HAST content in
livers of male and female rats. Hepatic contents of
HAST in Sprague-Dawley rats were determined by
Western blotting using anti-HAST antibodies.
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Figure 7. Correlation of hepatic contents of HAST and
N-hydroxy-2-acetylaminofluorene sulfating activity in
livers of rats with different growth hormone and thy-
roid hormone levels. Open and closed symbols indicate
male and female animals, respectively. Cont, intact; H,
hypophysectomized; GHs, injected growth hormone
twice a day for 7 days; GHi, infused growth hormone
by constant infusion for 7 days; and T3, treated with
triiodothyronine for 7 days.
intact female rats with castration of male
animals. Treatment ofcastrated male or of
female rats with 10 mg/kg of testosterone
propionate for 1 week increased hepatic
content ofHASTs. HAST levels also varied
during development. The contents were
low and did not differ between the sexes
until 4 weeks ofage, but the sex-related dif-
ference became clear at around 5 weeks of
age (Figure 6). These results are in accor-
dance with data reported on cytosolic-sul-
fating activities of N-hydroxy-2-acetyl-
aminofluorene (20,25), and confirmed the
identity ofHASTs as N-hydroxyarylamine-
activating sulfotransferases. On the cause of
the sex-related and developmental changes
in hepatic contents ofHASTs in rat livers,
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we showed that hepatic levels of HASTs
are under the influence ofpituitary growth
hormone and thyroid hormone using
hypophysectomized rats (8,26). As shown
in Figure 7, levels ofboth hepatic sulfation
of N-hydroxy-2-acetylaminofluorene and
content of HAST changed concordantly
with each other, depending on growth hor-
mone levels and administration mode. Both
the levels ofsulfating activity and HAST
content decreased to less than one-third
after hypophysectomy of male rats, which
was comparable to that ofintact female rats.
Intermittent injection ofgrowth hormone
twice a day for 7 days, which mimicked the
male secretory pattern, to hypophysec-
tomized rats increased both levels, while
supplement of growth hormone by con-
stant infusion, to mimic the female pattern,
had onlytrivial effect. These results indicate
that secretory profile and trough levels of
plasma growth hormone are the main
determinant of HASTs in rat livers.
Interestingly, Griffin et al. (27) observed in
1955 the association of a pituitary factor
on liver carcinogenicity of arylamines in
rats. In the study, arylamine-induced liver
tumorigenicity was decreased in hypophy-
sectomized rats, which is in good agreement
with decreased levels ofHAST in that con-
dition. We know now that phase I enzymes
such as P450 also are influenced by pitu-
itary growth hormone (28,29). Therefore,
we also should consider several factors
other than sulfation. But lowered levels of
hepatic sulfation may account in part for
the decreased sensitivity to carcinogenic
arylamines in hypophysectomized rats.
Pentachlorophenol (PCP) is known to
inhibit sulfotransferase-mediated activation
of N-hydroxyarylamines in experimental
animals (30). Both sulfation ofN-hydroxy-
2-acetylaminofluorene and PAPS-dependent
DNAbinding ofN-hydroxy-2-aminofluorene
were inhibited efficiently by the addition of
-20 pM PCP in human cytosolic systems
(7). In addition, cytosolic p-nitrophenol
sulfating activities were separated into two
fractions by DEAE-HPLC with a NaCl
gradient elution of human liver cytosols.
DNA binding ofN-hydroxy-2-aminofluo-
rene was not detectable in the first fraction,
but comigrated in the second fraction,
which contained a protein showing an
intense band around 33 kDa in Western
blots using a rat HAST antibody. These
results suggest that sulfation ofN-hydroxy-
arylamines in human livers is likely to be
catalyzed by an enzyme related to rat
HASTs. We have isolated several different
cDNA clones of rat sulfotransferases. In
Northern blots, a cDNA containing infor-
mation of a new form, STICI, hybridized
specifically with mRNA in livers of adult
male but not female rats. These data are
consistent with sex-specific and age-depen-
dent appearance of HAST protein in rat
livers. We are currently identifying STICI
properties.
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